全球靜脈通路裝置市場：按類型、插入途徑、應用、最終用戶和地區分類－預測至2031年

預計到 2031 年，靜脈通路裝置的市場規模將達到 86.8 億美元，而 2026 年為 62.7 億美元，2026 年至 2031 年的年複合成長率（CAGR）為 6.7%。

由於癌症、心臟病和腎衰竭等慢性疾病的增加，靜脈通路裝置市場正在擴張。所有這些疾病都需要靜脈治療。住院和手術次數的增加，以及對重症監護和急診醫學需求的成長，都在推動對這些裝置的需求。此外，諸如安全導向的裝置設計、抗菌塗層和超音波引導植入等技術進步，正在改善臨床療效，減少併發症，並促進靜脈通路裝置通路裝置的廣泛應用。此外，人口老化、門診和居家醫療設施的擴張，以及對感染控制和病人安全的高度重視，也正在推動醫療保健系統對靜脈通路裝置的需求。

“按類型分類，預計外周血靜脈通路裝置細分市場在預測期內將錄得最高的複合年成長率。”

按類型分類，周邊靜脈通路裝置裝置預計將成為靜脈通路裝置市場的主要驅動力，這主要得益於醫院和其他醫療機構對短期靜脈輸液治療需求的不斷成長。慢性病發病率的上升、外科手術和急診手術的增加以及靜脈注射藥物和液體使用量的擴大，進一步推動了對周邊靜脈通路裝置的需求。除了這些優勢外，與中心靜脈通路相比，周邊血管通路裝置還因其易於插入、成本效益高以及發生嚴重併發症的風險較低而備受青睞。此外，新型導管材料、旨在防止針刺傷的安全功能以及向門診護理和更經濟實惠的醫療保健模式的轉變，也都在促進市場成長。

“按應用領域分類，預計藥物管理領域在預測期內將實現最高的複合年成長率。”

按應用領域分類，藥物輸注領域預計將呈現最高的成長率，這主要得益於靜脈輸注療法在癌症、感染疾病、傳染病和自體免疫疾病等慢性疾病治療中的日益普及。此外，化療、抗生素、生物製藥和疼痛管理等領域對靜脈注射的依賴性不斷增強，也因其起效迅速和生物利用度高而推動了市場需求。同時，住院率的上升、門診靜脈輸注治療中心的擴張以及家庭靜脈輸注治療的普及也促進了該領域的成長。靜脈通路裝置的創新特性，例如更高的輸注精準度、更低的感染風險以及對長期藥物輸注的支持，正在推動其在醫療機構中的應用。

“按終端用戶細分市場來看，預計診所和門診中心細分市場在預測期內將呈現最高的成長率。”

診所和門診中心的興起是靜脈通路裝置市場成長的主要驅動力。這主要是由於醫院將患者轉移到門診治療的趨勢，預計這將降低整體醫療成本。此外，微創手術、靜脈輸液、慢性病管理和日間手術的推廣應用，也增加了這些場所對高效率、安全血管通路的需求。易於使用且併發症少的靜脈通路裝置是其在診所和門診手術中心（ASC）快速普及的關鍵因素。有利的保險報銷方案、患者對縮短康復時間的渴望以及獨立專科診所的增加，也是推動市場擴張的因素。

“預計亞太地區在預測期內將錄得最高的複合年成長率。”

門診服務和設施的擴張顯著推動了靜脈通路裝置市場的發展。由於門診就診成本更低、更便捷，醫院和患者越來越傾向於選擇門診而非住院治療。靜脈通路裝置在小規模手術、靜脈輸液、化療和慢性病管理中的廣泛應用也促進了市場成長。此外，技術的進步使得這些裝置能夠快速、無菌、便利地插入，從而更具吸引力。其他推動靜脈通路裝置在診所和門診中心應用的因素還包括：有利的保險報銷政策、快速的手術實施以及患者對當日治療日益成長的需求。

靜脈通路裝置市場的主要參與者

市場的主要參與者包括 Becton, Dickinson and Company（美國）、Teleflex Incorporated（美國）、ICU Medical, Inc.（美國）、B. Braun SE（德國）、AngioDynamics, Inc.（美國）、Medtronic, Plc（愛爾蘭）、Merit Medical Systems Inc.（美國）、Terumo Corporation（日本）、法文Inc.（美國）、HealthLine Medical Products（美國）、Cook Medical（美國）和 Access Vascular, Inc.（美國）。

調查範圍：

本報告分析了靜脈通路裝置市場，旨在基於血管成形術支架、血管支架、下腔靜脈濾器、導管、血管成形術球囊、斑塊改良裝置、血管成形術用氣球動力學裝置、其他裝置以及終端用戶等多個細分市場，估算其市場規模和未來成長潛力。報告包含市面上各種靜脈通路裝置的產品系列矩陣。此外，該報告還對該市場的主要參與者說明了競爭分析，包括公司簡介、產品線和關鍵市場策略。

購買本報告的理由

本報告透過提供關於靜脈通路裝置市場整體及各細分市場銷售額的最準確預測，幫助市場領導和新參與企業更了解市場。報告有助於相關人員了解競爭格局，更好地定位自身業務，並深入洞察市場動態，制定合適的打入市場策略。此外，報告還幫助相關人員了解市場趨勢，並提供關鍵市場促進因素、限制因素、挑戰和機會的資訊。

本報告深入分析了以下幾點：

• 關鍵促進因素（文明病的盛行率增加、化療程序數量增加、兒童患者靜脈通路裝置的使用範圍擴大）、阻礙因素（靜脈通路裝置的植入和維護高成本、產品召回和故障）、挑戰（熟練專家短缺、靜脈通路裝置相關的風險）和機會（技術進步、醫院數量增加）的分析。
• 產品改進與創新：靜脈通路裝置市場新產品發布和預期趨勢的全面詳細資訊。
• 產品開發與創新：深入洞察靜脈通路裝置市場的未來趨勢、研發活動和新產品發布。
• 市場發展：提供有關盈利新興市場的全面信息，按最終用戶細分，包括血管成形術支架、結構性心臟裝置、導管、血管成形術用氣球、斑塊改良裝置、血流動力學改良裝置和其他裝置。
• 市場多元化：靜脈通路裝置市場的新產品和服務、產品和服務改進、快速成長的地區、近期趨勢和投資的全面資訊。
• 競爭分析：對靜脈通路裝置市場主要競爭對手的市場佔有率、成長計畫、產品和服務以及生產能力進行全面評估。

目錄

第1章：引言

第2章執行摘要

第3章重要考察

第4章 市場概覽

• 市場動態
  • 促進因素
  • 抑制因子
  • 機會
  • 任務
• 未滿足的需求和未開發的領域
• 相互關聯的市場與跨產業機遇
• 一級/二級/三級公司的策略性舉措

第5章 產業趨勢

• 波特五力分析
• 宏觀經濟展望
• 供應鏈分析
• 價值鏈分析
• 生態系分析
• 價格分析
• 貿易分析
• 2026-2027 年主要會議和活動
• 影響我們客戶公司業務的趨勢/變化
• 投資和資金籌措場景
• 案例研究分析
• 美國關稅對靜脈通路裝置市場的影響

第6章：技術進步、人工智慧的影響、專利、創新與未來應用

• 主要新興技術
• 互補技術
• 鄰近技術
• 技術/產品藍圖
• 專利分析
• 未來應用
• 人工智慧/生成式人工智慧對靜脈通路裝置市場的影響

第7章：監理情勢與永續性舉措

• 當地法規和合規性
• 業界標準
• 對永續性的承諾

第8章：顧客趨勢與購買行為

• 決策流程
• 主要採購相關人員及其評估標準
• 實施障礙和內部挑戰
• 各個終端用戶產業尚未滿足的需求
• 市場盈利

第9章：靜脈通路裝置市場（按類型分類）

• 中心靜脈通路裝置
• 靜脈通路裝置
• 配件
• 骨內靜脈通路裝置

第10章：靜脈通路裝置市場（依插入途徑分類）

• 靜脈
• 皮下
• 骨內

第11章：靜脈通路裝置市場（依應用領域分類）

• 藥物管理
• 液體和營養輸注
• 輸血
• 診斷和檢查

第12章：靜脈通路裝置市場（依最終用戶分類）

• 醫院
• 診所
• 門診部
• 其他

第13章：靜脈通路裝置市場（按地區分類）

• 北美洲
  • 北美宏觀經濟展望
  • 北美中心靜脈通路裝置市場按類型（單位）銷售量分析
  • 北美周邊血管靜脈通路裝置市場按類型（單位）銷售量分析
  • 美國
  • 加拿大
• 歐洲
  • 歐洲宏觀經濟展望
  • 歐洲中心靜脈通路裝置市場按類型（單位）銷售量分析
  • 歐洲周邊血管靜脈通路裝置市場按類型（單位）銷售量分析
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 其他
• 亞太地區
  • 亞太地區宏觀經濟展望
  • 亞太地區中心靜脈通路裝置市場按類型分類的銷售量分析（單位：台）
  • 亞太地區周邊血管靜脈通路裝置市場按類型（單位）銷售量分析
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 其他
• 拉丁美洲
  • 拉丁美洲宏觀經濟展望
  • 拉丁美洲中心靜脈通路裝置市場按類型（單位）銷售量分析
  • 拉丁美洲周邊血管靜脈通路裝置市場按類型（單位）銷售量分析
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
• 中東和非洲
  • 中東和非洲宏觀經濟展望
  • 中東和非洲中心靜脈通路裝置市場按類型（單位）分類的銷售量分析
  • 中東和非洲周邊血管靜脈通路裝置市場按類型（單位）銷售量分析
  • 海灣合作理事會國家
  • 其他

第14章 競爭格局

• 主要參與企業的競爭策略/優勢，2024-2026 年
• 2023-2025年收入分析
• 2025年市佔率分析
• 企業估值矩陣：主要公司，2025 年
• 公司估值矩陣：新創企業/中小企業，2024 年
• 企業估值和財務指標
• 品牌/產品對比
• 競爭格局

第15章：公司簡介

• 主要參與企業
  • BECTON, DICKINSON AND COMPANY
  • TERUMO CORPORATION
  • TELEFLEX INCORPORATED
  • ICU MEDICAL INC.
  • B. BRAUN SE
  • MERIT MEDICAL SYSTEMS
  • NIPRO CORPORATION
  • VYGON
  • ANGIODYNAMICS
  • MOZARC MEDICAL HOLDING LLC
  • SPECTRUM VASCULAR
  • AMECATH
  • MEDICAL COMPONENTS, INC.
  • HEALTHLINE MEDICAL PRODUCTS
  • ACCESS VASCULAR, INC.
• 其他公司
  • ARGON MEDICAL DEVICES
  • PAKUMED MEDICAL PRODUCTS GMBH
  • GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
  • PFM MEDICAL GMBH
  • MEDI-TECH DEVICES PVT. LTD.
  • KIMAL
  • POLYMED
  • DELTA MED SPA
  • NEWTECH MEDICAL DEVICES PVT. LTD.
  • SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.

第16章調查方法

第17章附錄

The vascular access device market is projected to reach USD 8.68 billion by 2031 from USD 6.27 billion in 2026, at a CAGR of 6.7% from 2026 to 2031.

The vascular access device market is expanding due to the rise in chronic diseases such as cancer, heart disorders, and kidney failure, all of which require intravenous therapies. The increase in hospitalizations, surgical procedures, and the demand for critical care and emergency services is driving the need for these devices. Additionally, advancements in technology-such as safety-engineered devices, antimicrobial coatings, and ultrasound-guided placement-are enhancing clinical outcomes, reducing complications, and supporting broader adoption of vascular access devices. Besides, the growing elderly population, rising ambulatory care and home healthcare facilities, and the tremendous emphasis on infection control and patient safety are all driving the demand for vascular access devices in the healthcare system.

"Based on type, the peripheral vascular access device segment is expected to experience the highest CAGR during the forecast period."

By type, the peripheral vascular access device segment is estimated to lead the vascular access device market because of the increasing need for short-term intravenous therapy in hospitals and other medical facilities. The demand for peripheral vascular access devices has been further propelled by the rise in chronic diseases, surgical and emergency procedures, and increased use of IV medications and fluids. Apart from these benefits, the devices are also preferred for their insertion convenience, cost, and lower risk of severe complications than central access. Moreover, new catheter materials, engineered safety designs that avoid needlestick injury, and a movement toward outpatient and more affordable care models are also contributing to the market's growth.

"Based on application, the drug administration segment is projected to register the highest CAGR during the forecast period."

By application, the drug administration segment is projected to grow at the highest rate due to the increasing use of intravenous therapies in the treatment of chronic illnesses like cancer, heart diseases, infections, and autoimmune disorders. Demand is additionally supported by increasing dependence on IV drug delivery for chemotherapy, antibiotics, biologics, and pain management, owing to its rapid onset and higher bioavailability. Besides, the increase in hospital admissions, the extension of outpatient infusion centers, and home-based IV therapy are all contributing to the segment's growth. The innovative features of vascular access devices, such as better dosing accuracy, lower infection risks, and long-term drug delivery support, are all contributing to their adoption in healthcare settings.

"Based on end user, the clinic & ambulatory care centers segment is expected to grow at the highest rate during the forecast period."

The rise of clinics and ambulatory care centers has been a major factor in the growth of the vascular access device market, mainly driven by the trend of hospitals moving patients to outpatient care, which, in turn, is expected to cut down on overall healthcare costs. Besides, the scale-up of minimally invasive procedures, infusion therapies, chronic disease management, and same-day surgeries has contributed to the need for efficient and safe vascular access in these environments. Access to easy-to-use, low-complication vascular access devices is a major factor behind the rapid adoption by clinics and ASCs. Also, favorable reimbursement systems, patient preference for shorter recovery times, and the growth of stand-alone specialty clinics are some of the reasons further contributing to the market expansion.

"Asia Pacific is estimated to register the highest CAGR during the forecast period."

The growth of outpatient services and facilities has significantly boosted the vascular access device market. Hospitals and patients are increasingly shifting their preference from inpatient to outpatient services due to the cost savings and reduced inconvenience associated with outpatient care. The rising use of vascular access devices for small surgeries, infusion therapies, chemotherapy administration, and chronic disease management has also contributed to market growth. Additionally, advancements in technology have enabled the quick, sterile, and straightforward insertion of these devices, further enhancing their appeal. Other favorable factors for the use of vascular access devices in clinics and ambulatory care centers include supportive reimbursement policies, quick procedure turnaround times, and patients' growing preference for same-day treatments.

Key players in the vascular access device market

Some of the major players in this market are Becton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Medtronic, Plc (Ireland), Merit Medical Systems Inc. (US), Terumo Corporation (Japan), Nipro (Japan), Vygon (France), AMECATH (Egypt), Medical Components, Inc. (US), HealthLine Medical Products (US), Cook Medical (US), and Access Vascular, Inc. (US).

Research Coverage:

The report analyzes the vascular access device market and aims to estimate its size and future growth potential based on various segments, such as angioplasty stents, endovascular aneurysm repair stent grafts, inferior cava filters, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users. The report includes a product portfolio matrix of various vascular access devices available in the market. It also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall vascular access device market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key divers (Growing prevalence of lifestyle diseases, increasing number of chemotherapy procedures, growing use of vascular access devices in pediatric patients), restraints (High cost associated with placement and maintenance of vascular access device, product recalls and failures), challenges (Shortage of skilled professionals, risks associated with vascular access devices), and opportunities (Technological Advancements, growth in number of hospitals)
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the vascular access device market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the vascular access device market
• Market Development: Comprehensive information on the lucrative emerging markets by angioplasty stents, structural heart devices, catheters, angioplasty balloons, plaque modification devices, hemodynamic flow alteration devices, other devices, and end users.
• Market Diversification: Exhaustive information about new products and services or product and service enhancements, growing geographies, recent developments, and investments in the vascular access device market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the vascular access device market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS IN VASCULAR ACCESS DEVICE MARKET
• 2.4 HIGH GROWTH SEGMENTS
• 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 VASCULAR ACCESS DEVICE MARKET OVERVIEW
• 3.2 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY AND END USER
• 3.3 GEOGRAPHIC SNAPSHOT OF VASCULAR ACCESS DEVICE MARKET

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising global prevalence of chronic and lifestyle-related diseases
    • 4.2.1.2 Rapid growth in the geriatric population and associated vascular disease burden
    • 4.2.1.3 Favorable reimbursement scenario for vascular procedures
    • 4.2.1.4 Increase in cancer incidence driving demand for vascular access devices in chemotherapy
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 High costs of vascular access device placement and maintenance
    • 4.2.2.2 Rising product failures and device recalls
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Technological innovation in vascular access devices
    • 4.2.3.2 Growing adoption of midline catheters in clinical and outpatient settings
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Clinical complications associated with vascular access devices
    • 4.2.4.2 Shortage of skilled professionals for vascular access device placement and management
• 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.3.1 UNMET NEEDS IN VASCULAR ACCESS DEVICE MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 BARGAINING POWER OF SUPPLIERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC OUTLOOK
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS & FORECAST
  • 5.2.3 TRENDS IN GLOBAL MEDICAL DEVICES INDUSTRY
  • 5.2.4 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE TREND OF CENTRAL VENOUS ACCESS DEVICES, BY TYPE (2023-2025)
  • 5.6.2 AVERAGE SELLING PRICE TREND OF PERIPHERAL VASCULAR ACCESS DEVICES, BY TYPE (2023-2025)
  • 5.6.3 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY APPLICATION (2023-2025)
  • 5.6.4 AVERAGE SELLING PRICE TREND, BY REGION (2023-2025)
• 5.7 TRADE ANALYSIS
  • 5.7.1 IMPORT DATA FOR HS CODE 9018.39
  • 5.7.2 EXPORT DATA FOR HS CODE 9018.39
• 5.8 KEY CONFERENCES & EVENTS, 2026-2027
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.10 INVESTMENT & FUNDING SCENARIO
• 5.11 CASE STUDY ANALYSIS
• 5.12 IMPACT OF US TARIFFS-VASCULAR ACCESS DEVICE MARKET
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 PRICE IMPACT ANALYSIS
  • 5.12.4 IMPACT ON COUNTRIES/REGIONS
  • 5.12.5 IMPACT ON END-USE INDUSTRIES
    • 5.12.5.1 Hospitals
    • 5.12.5.2 Clinics
    • 5.12.5.3 Ambulatory care centers
    • 5.12.5.4 Other end users

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 NEEDLE-FREE AND CLOSED IV SYSTEMS
  • 6.1.2 ULTRASOUND-GUIDED AND TIP-NAVIGATION SYSTEMS
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 VEIN VISUALIZATION SYSTEMS
  • 6.2.2 INFUSION PUMPS AND FLOW CONTROL SYSTEMS
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 ULTRASOUND SYSTEMS FOR VASCULAR ACCESS
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.4.1 NEAR TERM (2025-2027)
  • 6.4.2 MID TERM (2028-2030)
  • 6.4.3 LONG TERM (2030+)
• 6.5 PATENT ANALYSIS
  • 6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS
• 6.6 FUTURE APPLICATIONS
  • 6.6.1 HOME-BASED AND REMOTE INFUSION THERAPIES
  • 6.6.2 SMART VASCULAR ACCESS DEVICES WITH SENSOR INTEGRATION
  • 6.6.3 EXPANSION OF CRITICAL CARE AND EXTRACORPOREAL THERAPIES
  • 6.6.4 ULTRASOUND-GUIDED AND ROBOTIC VASCULAR ACCESS PLACEMENT
  • 6.6.5 ADVANCED ANTIMICROBIAL AND BIOCOMPATIBLE CATHETER TECHNOLOGIES
  • 6.6.6 PRECISION MEDICINE AND SPECIALIZED DRUG DELIVERY APPLICATIONS
• 6.7 IMPACT OF AI/GENERATIVE AI ON VASCULAR ACCESS DEVICE MARKET
  • 6.7.1 BEST PRACTICES IN VASCULAR ACCESS DEVICE MARKET
  • 6.7.2 CASE STUDIES OF AI IMPLEMENTATION IN VASCULAR ACCESS DEVICE MARKET
  • 6.7.3 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
  • 6.7.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN VASCULAR ACCESS DEVICE MARKET

7 REGULATORY LANDSCAPE & SUSTAINABILITY INITIATIVES

• 7.1 REGIONAL REGULATIONS & COMPLIANCE
  • 7.1.1 REGULATORY ANALYSIS
    • 7.1.1.1 North America
      • 7.1.1.1.1 US
      • 7.1.1.1.2 Canada
    • 7.1.1.2 Europe
    • 7.1.1.3 Asia Pacific
    • 7.1.1.4 Latin America
    • 7.1.1.5 Middle East & Africa
  • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 7.2 INDUSTRY STANDARDS
  • 7.2.1 QUALITY MANAGEMENT SYSTEM FOR MEDICAL DEVICES (ISO 13485)
  • 7.2.2 BIOLOGICAL EVALUATION OF MEDICAL DEVICES (ISO 10993)
  • 7.2.3 INTRAVASCULAR CATHETERS (ISO 10555)
  • 7.2.4 RISK MANAGEMENT FOR MEDICAL DEVICES (ISO 14971)
• 7.3 SUSTAINABILITY INITIATIVES
  • 7.3.1 ENVIRONMENTAL SUSTAINABILITY IN VASCULAR ACCESS PRODUCT LIFECYCLE- BECTON, DICKINSON AND COMPANY
  • 7.3.2 RESOURCE EFFICIENCY AND WASTE REDUCTION IN MEDICAL DEVICE MANUFACTURING - VYGON
  • 7.3.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
  • 7.3.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 KEY BUYER STAKEHOLDERS AND THEIR EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 BUYING CRITERIA
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
• 8.5 MARKET PROFITABILITY

9 VASCULAR ACCESS DEVICE MARKET, BY TYPE

• 9.1 INTRODUCTION
• 9.2 CENTRAL VENOUS ACCESS DEVICES
  • 9.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS
    • 9.2.1.1 Enhanced convenience and risk reduction boost PICC adoption
  • 9.2.2 TUNNELED CATHETERS
    • 9.2.2.1 Advantages of tunneled catheters, such as lower risk of infection and lower chances of accidental removal, to boost demand
    • 9.2.2.2 Volume analysis for tunneled cathers market, by region, 2024-2031 (Units)
  • 9.2.3 NON-TUNNELED CATHETERS
    • 9.2.3.1 Increasing adoption of non-tunneled CVCs driven by affordability and their critical role in emergency care
    • 9.2.3.2 Volume analysis for non-tunneled cathers market, by region, 2024-2031 (Units)
  • 9.2.4 IMPLANTABLE PORTS
    • 9.2.4.1 Implantable conventional ports
      • 9.2.4.1.1 Lowest risk of infection associated with implanted ports to support growth
    • 9.2.4.2 Implantable power injectable ports
      • 9.2.4.2.1 Increasing chemotherapy treatments and high-flow infusion needs fuel demand for implantable power injectable ports
• 9.3 PERIPHERAL VASCULAR ACCESS DEVICES
  • 9.3.1 PERIPHERAL VENOUS ACCESS DEVICES
    • 9.3.1.1 Peripheral intravenous catheters
      • 9.3.1.1.1 Growing hospitalizations and widespread IV therapy drive demand for peripheral intravenous catheters in healthcare
    • 9.3.1.2 Volume analysis for peripheral intravenous catheters market, by region, 2024-2031 (Units)
    • 9.3.1.3 Midline catheters
      • 9.3.1.3.1 Cost-efficiency and extended treatment capabilities drive midline catheter growth in vascular access markets
      • 9.3.1.3.2 MST max barrier midline catheters
      • 9.3.1.3.3 Integrated/Accelerated midline catheters
    • 9.3.1.4 Butterfly/Winged steel needles
      • 9.3.1.4.1 Wide usage of winged steel needles in blood sampling and diagnosis to propel growth
  • 9.3.2 PERIPHERAL ARTERIAL ACCESS DEVICES
    • 9.3.2.1 Real-time hemodynamic monitoring in critical and surgical care to drive market
    • 9.3.2.2 Volume analysis for peripheral arterial access devices market, by region, 2024-2031 (Units)
• 9.4 ACCESSORIES
  • 9.4.1 RECURRENT NEED FOR ACCESSORIES TO BOOST MARKET
• 9.5 INTRAOSSEOUS VASCULAR ACCESS DEVICES
  • 9.5.1 INCREASING INCIDENCE OF CARDIAC ARRESTS TO DRIVE DEMAND FOR INTRAOSSEOUS VASCULAR ACCESS DEVICES

10 VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION

• 10.1 INTRODUCTION
• 10.2 INTRAVENOUS
  • 10.2.1 GROWING HOSPITALIZATIONS AND DEMAND FOR FAST THERAPEUTIC EFFECTS DRIVE USAGE OF INTRAVENOUS ROUTE
• 10.3 SUBCUTANEOUS
  • 10.3.1 RISING CANCER CASES AND DEMAND FOR LONG-TERM THERAPIES DRIVE SEGMENTAL GROWTH
• 10.4 INTRAOSSEOUS
  • 10.4.1 RISING PREVALENCE OF CORONARY ARTERY DISEASES TO DRIVE MARKET GROWTH

11 VASCULAR ACCESS DEVICE MARKET, BY APPLICATION

• 11.1 INTRODUCTION
• 11.2 DRUG ADMINISTRATION
  • 11.2.1 CHEMOTHERAPY
    • 11.2.1.1 Rising cancer cases to propel chemotherapy demand and boost market growth
  • 11.2.2 OTHER DRUG ADMINISTRATION APPLICATIONS
• 11.3 FLUID & NUTRITION ADMINISTRATION
  • 11.3.1 GROWING USE OF PERIPHERAL VASCULAR ACCESS DEVICES FOR SHORT-TERM NUTRITIONAL THERAPY TO SUPPORT MARKET
• 11.4 BLOOD TRANSFUSION
  • 11.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION IN THE TREATMENT OF VARIOUS CONDITIONS TO BOOST GROWTH
• 11.5 DIAGNOSTICS & TESTING
  • 11.5.1 GROWING POPULARITY OF PERIPHERAL LINES FOR DIAGNOSTIC & TESTING APPLICATIONS TO DRIVE MARKET GROWTH

12 VASCULAR ACCESS DEVICE MARKET, BY END USER

• 12.1 INTRODUCTION
• 12.2 HOSPITALS
  • 12.2.1 PUBLIC HOSPITALS
    • 12.2.1.1 Affordability and accessibility drive patients toward public hospitals
  • 12.2.2 PRIVATE HOSPITALS
    • 12.2.2.1 Rising availability of specialized treatments and diagnostic services in private hospitals fuels growth
• 12.3 CLINICS
  • 12.3.1 INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO PROPEL MARKET
• 12.4 AMBULATORY CARE CENTERS
  • 12.4.1 INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO SUPPORT MARKET GROWTH
• 12.5 OTHER END USERS

13 VASCULAR ACCESS DEVICE MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 13.2.2 NORTH AMERICA VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.2.3 NORTH AMERICA VOLUME ANALYSIS FOR PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.2.4 US
    • 13.2.4.1 US to dominate North American vascular access device market during forecast period
  • 13.2.5 CANADA
    • 13.2.5.1 Rising cancer prevalence and advanced research initiatives propel Canada's vascular access device market growth.
• 13.3 EUROPE
  • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 13.3.2 EUROPE VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.3.3 EUROPE VOLUME ANALYSIS FOR PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.3.4 GERMANY
    • 13.3.4.1 Germany to dominate European vascular access device market during forecast period
  • 13.3.5 UK
    • 13.3.5.1 Increased need for intravenous treatments due to CKD and CHD drives market growth
  • 13.3.6 FRANCE
    • 13.3.6.1 Growing elderly population and healthcare needs foster rapid market growth for vascular access devices in France
  • 13.3.7 ITALY
    • 13.3.7.1 Strong healthcare policies by government to propel growth
  • 13.3.8 SPAIN
    • 13.3.8.1 Growing geriatric population to increase demand for vascular access devices
  • 13.3.9 REST OF EUROPE
• 13.4 ASIA PACIFIC
  • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 13.4.2 ASIA PACIFIC: VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.4.3 ASIA PACIFIC: VOLUME ANALYSIS FOR PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.4.4 CHINA
    • 13.4.4.1 China to dominate Asia Pacific's vascular access device market during forecast period.
  • 13.4.5 INDIA
    • 13.4.5.1 Increasing healthcare expenditure and chronic disease prevalence support market growth in India
  • 13.4.6 JAPAN
    • 13.4.6.1 Growing healthcare needs among elderly individuals fuel vascular access device market expansion in Japan.
  • 13.4.7 AUSTRALIA
    • 13.4.7.1 Rising demand for pharmaceuticals and increasing advancements in drug formulations to drive market
  • 13.4.8 SOUTH KOREA
    • 13.4.8.1 Increasing diabetes and CKD prevalence to drive the market growth
  • 13.4.9 REST OF ASIA PACIFIC
• 13.5 LATIN AMERICA
  • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 13.5.2 LATIN AMERICA: VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.5.3 LATIN AMERICA: VOLUME ANALYSIS FOR PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.5.4 BRAZIL
    • 13.5.4.1 Expanding chronic disease prevalence in Brazil supports demand growth
  • 13.5.5 MEXICO
    • 13.5.5.1 Growing ESRD cases and obesity trends to propel market growth
  • 13.5.6 REST OF LATIN AMERICA
• 13.6 MIDDLE EAST & AFRICA
  • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 13.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.6.3 MIDDLE EAST & AFRICA: VOLUME ANALYSIS FOR CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE (UNITS)
  • 13.6.4 GCC COUNTRIES
    • 13.6.4.1 Kingdom of Saudi Arabia
      • 13.6.4.1.1 Rising chronic disease burden and strategic healthcare investments to drive market
    • 13.6.4.2 United Arab Emirates
      • 13.6.4.2.1 Healthcare infrastructural development and rising medical tourism to drive demand
    • 13.6.4.3 Rest of GCC Countries
  • 13.6.5 REST OF MIDDLE EAST & AFRICA

14 COMPETITIVE LANDSCAPE

• 14.1 INTRODUCTION
• 14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2024-2026
  • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICE MARKET
• 14.3 REVENUE ANALYSIS, 2023-2025
• 14.4 MARKET SHARE ANALYSIS, 2025
  • 14.4.1 GLOBAL MARKET SHARE ANALYSIS (2025)
  • 14.4.2 US MARKET SHARE ANALYSIS (2025)
  • 14.4.3 EUROPE MARKET SHARE ANALYSIS (2025)
• 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 14.5.1 STARS
  • 14.5.2 EMERGING LEADERS
  • 14.5.3 PERVASIVE PLAYERS
  • 14.5.4 PARTICIPANTS
  • 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 14.5.5.1 Company footprint
    • 14.5.5.2 Type footprint
    • 14.5.5.3 Route of insertion footprint
    • 14.5.5.4 Application footprint
    • 14.5.5.5 Region footprint
• 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 14.6.1 PROGRESSIVE COMPANIES
  • 14.6.2 RESPONSIVE COMPANIES
  • 14.6.3 DYNAMIC COMPANIES
  • 14.6.4 STARTING BLOCKS
  • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 14.6.5.1 Detailed list of key startups/SMEs
    • 14.6.5.2 Competitive benchmarking of key startups/SMEs
• 14.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 14.7.1 FINANCIAL METRICS
  • 14.7.2 COMPANY VALUATION
• 14.8 BRAND/PRODUCT COMPARISON
• 14.9 COMPETITIVE SCENARIO
  • 14.9.1 PRODUCT LAUNCHES & APPROVALS
  • 14.9.2 DEALS
  • 14.9.3 EXPANSIONS
  • 14.9.4 OTHER DEVELOPMENTS

15 COMPANY PROFILES

• 15.1 KEY PLAYERS
  • 15.1.1 BECTON, DICKINSON AND COMPANY
    • 15.1.1.1 Business overview
    • 15.1.1.2 Products offered
    • 15.1.1.3 Recent developments
      • 15.1.1.3.1 Product launches & approvals
      • 15.1.1.3.2 Other developments
    • 15.1.1.4 MnM view
      • 15.1.1.4.1 Right to win
      • 15.1.1.4.2 Strategic choices
      • 15.1.1.4.3 Weaknesses & competitive threats
  • 15.1.2 TERUMO CORPORATION
    • 15.1.2.1 Business overview
    • 15.1.2.2 Products offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Product launches & approvals
      • 15.1.2.3.2 Expansions
      • 15.1.2.3.3 Other developments
  • 15.1.3 TELEFLEX INCORPORATED
    • 15.1.3.1 Business overview
    • 15.1.3.2 Products offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Product launches & approvals
      • 15.1.3.3.2 Deals
      • 15.1.3.3.3 Other developments
    • 15.1.3.4 MnM view
      • 15.1.3.4.1 Right to win
      • 15.1.3.4.2 Strategic choices
      • 15.1.3.4.3 Weaknesses & competitive threats
  • 15.1.4 ICU MEDICAL INC.
    • 15.1.4.1 Business overview
    • 15.1.4.2 Products offered
    • 15.1.4.3 Recent developments
      • 15.1.4.3.1 Product launches & approvals
      • 15.1.4.3.2 Expansions
      • 15.1.4.3.3 Other developments
    • 15.1.4.4 MnM view
      • 15.1.4.4.1 Right to win
      • 15.1.4.4.2 Strategic choices
      • 15.1.4.4.3 Weaknesses & competitive threats
  • 15.1.5 B. BRAUN SE
    • 15.1.5.1 Business overview
    • 15.1.5.2 Products offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Product launches & approvals
      • 15.1.5.3.2 Other developments
    • 15.1.5.4 MnM view
      • 15.1.5.4.1 Right to win
      • 15.1.5.4.2 Strategic choices
      • 15.1.5.4.3 Weaknesses and competitive threats
  • 15.1.6 MERIT MEDICAL SYSTEMS
    • 15.1.6.1 Business overview
    • 15.1.6.2 Products offered
    • 15.1.6.3 Recent developments
      • 15.1.6.3.1 Product launches
      • 15.1.6.3.2 Deals
      • 15.1.6.3.3 Other developments
  • 15.1.7 NIPRO CORPORATION
    • 15.1.7.1 Business overview
    • 15.1.7.2 Products offered
    • 15.1.7.3 Recent developments
      • 15.1.7.3.1 Deals
      • 15.1.7.3.2 Expansions
      • 15.1.7.3.3 Other developments
    • 15.1.7.4 MnM view
      • 15.1.7.4.1 Right to Win
      • 15.1.7.4.2 Strategic choices
      • 15.1.7.4.3 Weaknesses & competitive threats
  • 15.1.8 VYGON
    • 15.1.8.1 Business overview
    • 15.1.8.2 Products offered
    • 15.1.8.3 Recent developments
      • 15.1.8.3.1 Deals
  • 15.1.9 ANGIODYNAMICS
    • 15.1.9.1 Business overview
    • 15.1.9.2 Products offered
    • 15.1.9.3 Recent developments
      • 15.1.9.3.1 Product launches and approvals
  • 15.1.10 MOZARC MEDICAL HOLDING LLC
    • 15.1.10.1 Business overview
    • 15.1.10.2 Products offered
    • 15.1.10.3 Recent developments
      • 15.1.10.3.1 Deals
      • 15.1.10.3.2 Other developments
  • 15.1.11 SPECTRUM VASCULAR
    • 15.1.11.1 Business overview
    • 15.1.11.2 Products offered
    • 15.1.11.3 Recent developments
      • 15.1.11.3.1 Deals
      • 15.1.11.3.2 Expansions
  • 15.1.12 AMECATH
    • 15.1.12.1 Business overview
    • 15.1.12.2 Products offered
  • 15.1.13 MEDICAL COMPONENTS, INC.
    • 15.1.13.1 Business overview
    • 15.1.13.2 Products offered
    • 15.1.13.3 Recent developments
      • 15.1.13.3.1 Product launches and approvals
  • 15.1.14 HEALTHLINE MEDICAL PRODUCTS
    • 15.1.14.1 Business overview
    • 15.1.14.2 Products offered
    • 15.1.14.3 Recent developments
      • 15.1.14.3.1 Deals
  • 15.1.15 ACCESS VASCULAR, INC.
    • 15.1.15.1 Business overview
    • 15.1.15.2 Products offered
    • 15.1.15.3 Recent developments
      • 15.1.15.3.1 Product launches and approvals
      • 15.1.15.3.2 Deals
      • 15.1.15.3.3 Other developments
• 15.2 OTHER PLAYERS
  • 15.2.1 ARGON MEDICAL DEVICES
  • 15.2.2 PAKUMED MEDICAL PRODUCTS GMBH
  • 15.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
  • 15.2.4 PFM MEDICAL GMBH
  • 15.2.5 MEDI-TECH DEVICES PVT. LTD.
  • 15.2.6 KIMAL
  • 15.2.7 POLYMED
  • 15.2.8 DELTA MED S.P.A.
  • 15.2.9 NEWTECH MEDICAL DEVICES PVT. LTD.
  • 15.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.

16 RESEARCH METHODOLOGY

• 16.1 RESEARCH DATA
  • 16.1.1 SECONDARY DATA
    • 16.1.1.1 Key data from secondary sources
  • 16.1.2 PRIMARY DATA
    • 16.1.2.1 Key data from primary sources
    • 16.1.2.2 Key industry insights
• 16.2 MARKET SIZE ESTIMATION
• 16.3 GROWTH FORECAST
• 16.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 16.5 MARKET RANKING ANALYSIS
• 16.6 STUDY ASSUMPTIONS
• 16.7 RESEARCH LIMITATIONS
  • 16.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 16.7.2 SCOPE-RELATED LIMITATIONS
• 16.8 RISK ASSESSMENT

17 APPENDIX

• 17.1 DISCUSSION GUIDE
• 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 17.3 CUSTOMIZATION OPTIONS
  • 17.3.1 PRODUCT ANALYSIS
  • 17.3.2 GEOGRAPHIC ANALYSIS
  • 17.3.3 COMPANY INFORMATION
• 17.4 RELATED REPORTS
• 17.5 AUTHOR DETAILS

List of Tables

• TABLE 1 VASCULAR ACCESS DEVICE MARKET: INCLUSIONS & EXCLUSIONS
• TABLE 2 STANDARD CURRENCY CONVERSION RATES
• TABLE 3 DIABETES POPULATION, BY REGION, 2024 VS. 2050
• TABLE 4 TOP 10 COUNTRIES WITH THE HIGHEST SMOKING RATE (2025)
• TABLE 5 GERIATRIC POPULATION, BY REGION (2015-2030)
• TABLE 6 US: REIMBURSEMENT FOR VASCULAR PROCEDURES (2026)
• TABLE 7 VASCULAR ACCESS DEVICE MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 8 GDP CHANGE, BY KEY COUNTRY, 2021-2030 (IN USD BILLION)
• TABLE 9 AVERAGE SELLING PRICE TREND OF CENTRAL VENOUS ACCESS DEVICES, BY TYPE (2023-2025) (USD)
• TABLE 10 AVERAGE SELLING PRICE TREND OF PERIPHERAL VASCULAR ACCESS DEVICES, BY TYPE (2023-2025) (USD)
• TABLE 11 AVERAGE SELLING PRICE TREND OF KEY PRODUCTS, BY APPLICATION (2023-2025) (USD)
• TABLE 12 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION (2023-2025) (USD)
• TABLE 13 IMPORT DATA FOR HS CODE 9018.39, BY COUNTRY, 2021-2025 (USD THOUSANDS)
• TABLE 14 EXPORT DATA FOR HS CODE 9018.39, BY COUNTRY, 2021-2025 (USD THOUSANDS)
• TABLE 15 VASCULAR ACCESS DEVICE MARKET: MAJOR CONFERENCES & EVENTS IN 2026-2027E
• TABLE 16 CASE STUDY 1: IMPROVING VASCULAR ACCESS OUTCOMES THROUGH STANDARDIZED VASCULAR ACCESS MANAGEMENT
• TABLE 17 CASE STUDY 2: REDUCING CATHETER-RELATED BLOODSTREAM INFECTIONS USING ANTIMICROBIAL CENTRAL VENOUS CATHETERS
• TABLE 18 CASE STUDY 3: IMPROVING VASCULAR ACCESS EFFICIENCY THROUGH ULTRASONOGRAPHY-GUIDED CATHETER PLACEMENT
• TABLE 19 US ADJUSTED RECIPROCAL TARIFF RATES
• TABLE 20 US: IMPACT OF TARIFFS
• TABLE 21 ASIA PACIFIC: IMPACT OF TARIFFS
• TABLE 22 EUROPE: IMPACT OF TARIFFS
• TABLE 23 VASCULAR ACCESS DEVICE MARKET: MAJOR PATENTS
• TABLE 24 BEST PRACTICES IN VASCULAR ACCESS DEVICE MARKET
• TABLE 25 BEST PRACTICES IN CASE STUDIES OF AI IMPLEMENTATION IN THE VASCULAR ACCESS DEVICE MARKET
• TABLE 26 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
• TABLE 27 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 28 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 29 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 30 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 31 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR ACCESS DEVICES
• TABLE 33 KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES, BY END USER
• TABLE 34 VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 35 CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 36 CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 37 PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 38 TUNNELED PRODUCT CATHETER BY KEY PLAYERS (2025)
• TABLE 39 TUNNELED CATHETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 40 TUNNELED CATHETERS MARKET VOLUME, BY REGION, 2024-2031 (UNITS)
• TABLE 41 NON-TUNNELED PRODUCT CATHETER BY KEY PLAYERS (2025)
• TABLE 42 NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 43 NON-TUNNELED CATHETERS MARKET VOLUME, BY REGION, 2024-2031 (UNITS)
• TABLE 44 IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 45 IMPLANTABLE PORTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 46 IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 47 IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 48 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 49 PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 50 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 51 PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 52 PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 53 PERIPHERAL INTRAVENOUS CATHETERS MARKET VOLUME, BY REGION, 2024-2031 (UNITS)
• TABLE 54 MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 55 MIDLINE CATHETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 56 MIDLINE CATHETER-MAX BARRIER PRODUCT PORTFOLIO BY PRODUCT TYPE AND COMPANY (2025)
• TABLE 57 MST MAX BARRIER MIDLINE CATHETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 58 MIDLINE CATHETER -INTEGRATED/ACCELERATED PRODUCT PORTFOLIO BY PRODUCT TYPE AND COMPANY (2025)
• TABLE 59 INTEGRATED/ACCELERATED MIDLINE CATHETERS MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 60 BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 61 PERIPHERAL ARTERIAL CATHTER PRODUCT BY KEY PLAYERS (2025)
• TABLE 62 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 63 PERIPHERAL ARTERIAL ACCESS DEVICES MARKET VOLUME, BY REGION, 2024-2031 (UNITS)
• TABLE 64 VASCULAR ACCESS DEVICE ACCESSORIES MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 65 INTRAOSSEOUS VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 66 VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 67 VASCULAR ACCESS DEVICE MARKET FOR INTRAVENOUS ROUTE, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 68 VASCULAR ACCESS DEVICE MARKET FOR SUBCUTANEOUS ROUTE, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 69 VASCULAR ACCESS DEVICE MARKET FOR INTRAOSSEOUS ROUTE, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 70 VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 71 VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 72 VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 73 VASCULAR ACCESS DEVICE MARKET FOR CHEMOTHERAPY, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 74 VASCULAR ACCESS DEVICE MARKET FOR OTHER DRUG ADMINISTRATION APPLICATIONS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 75 VASCULAR ACCESS DEVICE MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 76 VASCULAR ACCESS DEVICE MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 77 VASCULAR ACCESS DEVICE MARKET FOR DIAGNOSTICS & TESTING MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 78 VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 79 VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 80 VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 81 VASCULAR ACCESS DEVICE MARKET FOR PUBLIC HOSPITALS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 82 VASCULAR ACCESS DEVICE MARKET FOR PRIVATE HOSPITALS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 83 VASCULAR ACCESS DEVICE MARKET FOR CLINICS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 84 VASCULAR ACCESS DEVICE MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 85 VASCULAR ACCESS DEVICE MARKET FOR OTHER END USERS, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 86 VASCULAR ACCESS DEVICE MARKET, BY REGION, 2024-2031 (USD MILLION)
• TABLE 87 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 88 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 89 NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 90 NORTH AMERICA VOLUME ANALYSIS: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 91 NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 92 NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 93 NORTH AMERICA VOLUME ANALYSIS : PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 94 NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 95 NORTH AMERICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 96 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 97 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 98 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 99 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 100 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 101 US: KEY MACROINDICATORS
• TABLE 102 US: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 103 US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 104 US: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 105 US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 106 US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 107 US: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 108 US: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 109 US: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 110 US: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 111 US: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 112 US: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 113 CANADA: KEY MACROINDICATORS
• TABLE 114 CANADA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 115 CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 116 CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 117 CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 118 CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 119 CANADA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 120 CANADA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 121 CANADA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 122 CANADA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 123 CANADA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 124 CANADA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 125 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 126 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 127 EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 128 EUROPE VOLUME ANALYSIS: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 129 EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 130 EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 131 EUROPE VOLUME ANALYSIS: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 132 EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 133 EUROPE: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 134 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 135 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 136 EUROPE: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 137 EUROPE: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 138 EUROPE: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 139 GERMANY: KEY MACROINDICATORS
• TABLE 140 GERMANY: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 141 GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 142 GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 143 GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 144 GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 145 GERMANY: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 146 GERMANY: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 147 GERMANY: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 148 GERMANY: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 149 GERMANY: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 150 GERMANY: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 151 UK: KEY MACROINDICATORS
• TABLE 152 UK: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 153 UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 154 UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 155 UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 156 UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 157 UK: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 158 UK: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 159 UK: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 160 UK: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 161 UK: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 162 UK: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 163 FRANCE: KEY MACROINDICATORS
• TABLE 164 FRANCE: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 165 FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 166 FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 167 FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 168 FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 169 FRANCE: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 170 FRANCE: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 171 FRANCE: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 172 FRANCE: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 173 FRANCE: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 174 FRANCE: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 175 ITALY: KEY MACROINDICATORS
• TABLE 176 ITALY: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 177 ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 178 ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 179 ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 180 ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 181 ITALY: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 182 ITALY: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 183 ITALY: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 184 ITALY: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 185 ITALY: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 186 ITALY: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 187 SPAIN: KEY MACROINDICATORS
• TABLE 188 SPAIN: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 189 SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 190 SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 191 SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 192 SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 193 SPAIN: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 194 SPAIN: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 195 SPAIN: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 196 SPAIN: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 197 SPAIN: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 198 SPAIN: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 199 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 200 REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 201 REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 202 REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 203 REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 204 REST OF EUROPE: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 205 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 206 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 207 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 208 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 209 REST OF EUROPE: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 210 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 211 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 212 ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 213 ASIA PACIFIC: VOLUME ANLYSIS CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 214 ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 215 ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 216 ASIA PACIFIC: VOLUME ANALYSIS PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 217 ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 218 ASIA PACIFIC: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 219 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 220 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 221 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 222 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 223 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 224 CHINA: KEY MACROINDICATORS
• TABLE 225 CHINA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 226 CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 227 CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 228 CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 229 CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 230 CHINA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 231 CHINA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 232 CHINA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 233 CHINA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 234 CHINA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 235 CHINA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 236 INDIA: KEY MACROINDICATORS
• TABLE 237 INDIA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 238 INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 239 INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 240 INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 241 INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 242 INDIA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 243 INDIA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 244 INDIA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 245 INDIA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 246 INDIA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 247 INDIA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 248 JAPAN: KEY MACROINDICATORS
• TABLE 249 JAPAN: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 250 JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 251 JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 252 JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 253 JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 254 JAPAN: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 255 JAPAN: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 256 JAPAN: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 257 JAPAN: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 258 JAPAN: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 259 JAPAN: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 260 AUSTRALIA: KEY MACROINDICATORS
• TABLE 261 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 262 AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 263 AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 264 AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 265 AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 266 AUSTRALIA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 267 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 268 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 269 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 270 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 271 AUSTRALIA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 272 SOUTH KOREA: KEY MACROINDICATORS
• TABLE 273 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 274 SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 275 SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 276 SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 277 SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 278 SOUTH KOREA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 279 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 280 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 281 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 282 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 283 SOUTH KOREA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 284 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 285 REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 286 REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 287 REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 288 REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 289 REST OF ASIA PACIFIC: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 290 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 291 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 292 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 293 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 294 REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 295 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 296 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 297 LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 298 LATIN AMERICA:VOLUME ANALYSIS BY CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 299 LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 300 LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 301 LATIN AMERICA: VOLUME ANALYSIS BY PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 302 LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 303 LATIN AMERICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 304 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 305 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 306 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 307 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 308 LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 309 BRAZIL: KEY MACROINDICATORS
• TABLE 310 BRAZIL: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 311 BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 312 BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 313 BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 314 BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 315 BRAZIL: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 316 BRAZIL: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 317 BRAZIL: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 318 BRAZIL: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 319 BRAZIL: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 320 BRAZIL: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 321 MEXICO: KEY MACROINDICATORS
• TABLE 322 MEXICO: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 323 MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 324 MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 325 MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 326 MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 327 MEXICO: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 328 MEXICO: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 329 MEXICO: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 330 MEXICO: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 331 MEXICO: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 332 MEXICO: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 333 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 334 REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 335 REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 336 REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 337 REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 338 REST OF LATIN AMERICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 339 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 340 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 341 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 342 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 343 REST OF LATIN AMERICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 344 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY REGION, 2024-2031 (USD MILLION)
• TABLE 345 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 346 MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 347 MIDDLE EAST & AFRICA: VOLUME ANALYSIS CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 348 MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 349 MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 350 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PERIPHERAL VASCULAR ACCESS DEVICE TYPE, 2024-2031 (THOUSAND UNITS)
• TABLE 351 MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 352 MIDDLE EAST & AFRICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 353 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 354 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 355 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 356 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 357 MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 358 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY COUNTRY, 2024-2031 (USD MILLION)
• TABLE 359 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 360 GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 361 GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 362 GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 363 GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 364 GCC COUNTRIES: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 365 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 366 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 367 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 368 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 369 GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 370 KINGDOM OF SAUDI ARABIA: KEY MACROINDICATORS
• TABLE 371 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 372 KINGDOM OF SAUDI ARABIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 373 KINGDOM OF SAUDI ARABIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 374 KINGDOM OF SAUDI ARABIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 375 KINGDOM OF SAUDI ARABIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 376 KINGDOM OF SAUDI ARABIA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 377 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 378 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 379 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 380 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 381 KINGDOM OF SAUDI ARABIA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 382 UNITED ARAB EMIRATES: KEY MACROINDICATORS
• TABLE 383 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 384 UNITED ARAB EMIRATES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 385 UNITED ARAB EMIRATES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 386 UNITED ARAB EMIRATES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 387 UNITED ARAB EMIRATES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 388 UNITED ARAB EMIRATES: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 389 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 390 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 391 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 392 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 393 UNITED ARAB EMIRATES: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 394 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 395 REST OF GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 396 REST OF GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 397 REST OF GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 398 REST OF GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 399 REST OF GCC COUNTRIES: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 400 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 401 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 402 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 403 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 404 REST OF GCC COUNTRIES: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 405 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 406 REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 407 REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 408 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 409 REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 410 REST OF MIDDLE EAST & AFRICA: MIDLINE CATHETERS MARKET, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 411 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY ROUTE OF INSERTION, 2024-2031 (USD MILLION)
• TABLE 412 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY APPLICATION, 2024-2031 (USD MILLION)
• TABLE 413 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 414 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024-2031 (USD MILLION)
• TABLE 415 REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICE MARKET FOR HOSPITALS, BY TYPE, 2024-2031 (USD MILLION)
• TABLE 416 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR ACCESS DEVICE, JANUARY 2023-MAY 2026
• TABLE 417 VASCULAR ACCESS DEVICE MARKET: DEGREE OF COMPETITION
• TABLE 418 US VASCULAR ACCESS DEVICE MARKET: DEGREE OF COMPETITION
• TABLE 419 EUROPE VASCULAR ACCESS DEVICE MARKET: DEGREE OF COMPETITION
• TABLE 420 VASCULAR ACCESS DEVICE MARKET: TYPE FOOTPRINT
• TABLE 421 VASCULAR ACCESS DEVICE MARKET: ROUTE OF INSERTION FOOTPRINT
• TABLE 422 VASCULAR ACCESS DEVICE MARKET: APPLICATION FOOTPRINT
• TABLE 423 VASCULAR ACCESS DEVICE MARKET: REGION FOOTPRINT
• TABLE 424 VASCULAR ACCESS DEVICE MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 425 VASCULAR ACCESS DEVICE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SME PLAYERS
• TABLE 426 VASCULAR ACCESS DEVICE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-MAY 2026
• TABLE 427 VASCULAR ACCESS DEVICE MARKET: DEALS, JANUARY 2023-MAY 2026
• TABLE 428 VASCULAR ACCESS DEVICE MARKET: EXPANSIONS, JANUARY 2023-MAY 2026
• TABLE 429 VASCULAR ACCESS DEVICE MARKET: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 430 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
• TABLE 431 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
• TABLE 432 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
• TABLE 433 BECTON, DICKINSON AND COMPANY: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 434 TERUMO CORPORATION: COMPANY OVERVIEW
• TABLE 435 TERUMO CORPORATION: PRODUCTS OFFERED
• TABLE 436 TERUMO CORPORATION: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
• TABLE 437 TERUMO CORPORATION: EXPANSIONS, JANUARY 2023-MAY 2026
• TABLE 438 TERUMO CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 439 TELEFLEX INCORPORATED: COMPANY OVERVIEW
• TABLE 440 TELEFLEX INCORPORATED: PRODUCTS OFFERED
• TABLE 441 TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
• TABLE 442 TELEFLEX INCORPORATED: DEALS, JANUARY 2023-MAY 2026
• TABLE 443 TELEFLEX INCORPORATED: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 444 ICU MEDICAL, INC.: COMPANY OVERVIEW
• TABLE 445 ICU MEDICAL, INC.: PRODUCTS OFFERED
• TABLE 446 ICU MEDICAL, INC.: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
• TABLE 447 ICU MEDICAL, INC.: EXPANSIONS, JANUARY 2023-MAY 2026
• TABLE 448 ICU MEDICAL, INC.: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 449 B. BRAUN SE: COMPANY OVERVIEW
• TABLE 450 B. BRAUN SE: PRODUCTS OFFERED
• TABLE 451 B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023-MAY 2026
• TABLE 452 B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 453 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
• TABLE 454 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
• TABLE 455 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES, JANUARY 2023-MAY 2026
• TABLE 456 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2023-MAY 2026
• TABLE 457 MERIT MEDICAL SYSTEMS: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 458 NIPRO: COMPANY OVERVIEW
• TABLE 459 NIPRO CORPORATION: PRODUCTS OFFERED
• TABLE 460 NIPRO CORPORATION: DEALS, JANUARY 2023-MAY 2026
• TABLE 461 NIPRO CORPORATION: EXPANSIONS, JANUARY 2023-MAY 2026
• TABLE 462 NIPRO CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 463 VYGON: COMPANY OVERVIEW
• TABLE 464 VYGON: PRODUCTS OFFERED
• TABLE 465 VYGON: DEALS, JANUARY 2023-MAY 2026
• TABLE 466 ANGIODYNAMICS: COMPANY OVERVIEW
• TABLE 467 ANGIODYNAMICS: PRODUCTS OFFERED
• TABLE 468 ANGIODYNAMICS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-MAY 2026
• TABLE 469 MOZARC MEDICAL HOLDING LLC: COMPANY OVERVIEW
• TABLE 470 MOZARC MEDICAL HOLDING LLC: PRODUCTS OFFERED
• TABLE 471 MOZARC MEDICAL HOLDING LLC: DEALS, JANUARY 2023-MAY 2026
• TABLE 472 MOZARC MEDICAL HOLDING LLC: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 473 SPECTRUM VASCULAR: COMPANY OVERVIEW
• TABLE 474 SPECTRUM VASCULAR: PRODUCTS OFFERED
• TABLE 475 SPECTRUM VASCULAR: DEALS, JANUARY 2023-MAY 2026
• TABLE 476 SPECTRUM VASCULAR: EXPANSIONS, JANUARY 2023-MAY 2026
• TABLE 477 AMECATH: COMPANY OVERVIEW
• TABLE 478 AMECATH: PRODUCTS OFFERED
• TABLE 479 MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW
• TABLE 480 MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED
• TABLE 481 MEDICAL COMPONENTS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-MAY 2026
• TABLE 482 HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW
• TABLE 483 HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED
• TABLE 484 HEALTHLINE MEDICAL PRODUCTS: DEALS, JANUARY 2023-MAY 2026
• TABLE 485 ACCESS VASCULAR, INC.: COMPANY OVERVIEW
• TABLE 486 ACCESS VASCULAR, INC.: PRODUCTS OFFERED
• TABLE 487 ACCESS VASCULAR, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023-MAY 2026
• TABLE 488 ACCESS VASCULAR, INC.: DEALS, JANUARY 2023-MAY 2026
• TABLE 489 ACCESS VASCULAR, INC.: OTHER DEVELOPMENTS, JANUARY 2023-MAY 2026
• TABLE 490 ARGON MEDICAL DEVICES: COMPANY OVERVIEW
• TABLE 491 PAKUMED MEDICAL PRODUCTS GMBH: COMPANY OVERVIEW
• TABLE 492 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
• TABLE 493 PFM MEDICAL GMBH: COMPANY OVERVIEW
• TABLE 494 MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW
• TABLE 495 KIMAL: COMPANY OVERVIEW
• TABLE 496 POLYMED: COMPANY OVERVIEW
• TABLE 497 DELTA MED S.P.A.: COMPANY OVERVIEW
• TABLE 498 NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW
• TABLE 499 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW
• TABLE 500 VASCULAR STENTS MARKET: STUDY ASSUMPTIONS
• TABLE 501 VASCULAR STENTS MARKET: RISK ASSESSMENT ANALYSIS

List of Figures

• FIGURE 1 VASCULAR ACCESS DEVICE MARKET: MARKETS COVERED & REGIONS CONSIDERED
• FIGURE 2 MARKET SCENARIO
• FIGURE 3 GLOBAL VASCULAR ACCESS DEVICE MARKET, 2024-2031
• FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICE MARKET, 2024-2026
• FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VASCULAR ACCESS DEVICE MARKET
• FIGURE 6 HIGH-GROWTH SEGMENTS IN VASCULAR ACCESS DEVICE MARKET, 2026-2031
• FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN VASCULAR ACCESS DEVICE MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
• FIGURE 8 RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH
• FIGURE 9 HOSPITALS AND AMBULATORY CARE CENTERS ACCOUNT FOR LARGEST MARKET SHARE IN ASIA PACIFIC, 2025
• FIGURE 10 CHINA TO GROW AT HIGHEST CAGR TILL 2026-2031
• FIGURE 11 VASCULAR ACCESS DEVICE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 12 NEW CANCER CASES: BY COUNTRY, 2025 (MILLION)
• FIGURE 13 VASCULAR ACCESS DEVICE MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 14 VASCULAR ACCESS DEVICE MARKET: SUPPLY CHAIN ANALYSIS
• FIGURE 15 VASCULAR ACCESS DEVICE MARKET: VALUE CHAIN ANALYSIS
• FIGURE 16 VASCULAR ACCESS DEVICE MARKET: ECOSYSTEM ANALYSIS
• FIGURE 17 VASCULAR ACCESS DEVICE MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• FIGURE 18 VASCULAR ACCESS DEVICE MARKET: INVESTMENT & FUNDING SCENARIO (2023-2026)
• FIGURE 19 PERIPHERAL VENOUS ACCESS DEVICES: NUMBER OF GRANTED PATENT APPLICATIONS (JANUARY 2016-MAY 2026)
• FIGURE 20 TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2023-MAY 2026)
• FIGURE 21 KEY FEATURES OF AI/GENERATIVE AI IN VASCULAR ACCESS DEVICE MARKET
• FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VASCULAR ACCESS DEVICES
• FIGURE 23 KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES, BY END USER
• FIGURE 24 NORTH AMERICA: VASCULAR ACCESS DEVICE MARKET SNAPSHOT
• FIGURE 25 ASIA PACIFIC: VASCULAR ACCESS DEVICE MARKET SNAPSHOT
• FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS MARKET, 2023-2025
• FIGURE 27 GLOBAL: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
• FIGURE 28 US: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
• FIGURE 29 EUROPE: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025
• FIGURE 30 VASCULAR ACCESS DEVICE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
• FIGURE 31 VASCULAR ACCESS DEVICE MARKET: COMPANY FOOTPRINT
• FIGURE 32 VASCULAR ACCESS DEVICE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
• FIGURE 33 EV/EBITDA OF KEY VENDORS FOR VASCULAR ACCESS DEVICE
• FIGURE 34 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS FOR VASCULAR ACCESS DEVICES
• FIGURE 35 VASCULAR ACCESS DEVICE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 36 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2025)
• FIGURE 37 TERUMO CORPORATION: COMPANY SNAPSHOT (2025)
• FIGURE 38 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2025)
• FIGURE 39 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2025)
• FIGURE 40 B. BRAUN SE: COMPANY SNAPSHOT (2025)
• FIGURE 41 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2025)
• FIGURE 42 NIPRO CORPORATION: COMPANY SNAPSHOT (2025)
• FIGURE 43 ANGIODYNAMICS: COMPANY SNAPSHOT (2025)
• FIGURE 44 RESEARCH DESIGN
• FIGURE 45 PRIMARY SOURCES
• FIGURE 46 PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS
• FIGURE 48 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
• FIGURE 49 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
• FIGURE 50 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2025)
• FIGURE 51 SUPPLY-SIDE ANALYSIS: VASCULAR ACCESS DEVICE MARKET
• FIGURE 52 TOP-DOWN APPROACH
• FIGURE 53 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VASCULAR ACCESS DEVICES MARKET (2026-2031)
• FIGURE 54 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF VASCULAR ACCESS DEVICE MARKET (2025)
• FIGURE 55 DATA TRIANGULATION METHODOLOGY